Cat. No. 3130
Alternative Name: CBN
Chemical Name: 6,6,9-Trimethyl-3-pentyl-6H-benzo[c
Biological ActivityCB2 and CB1 receptor agonist (Ki values are 126 and 211 nM respectively). Inhibits adenylyl cyclase (EC50 values are 120 and 261 nM for CB1 and CB2 receptors respectively) and suppresses immune cell function. Major constituent of cannabis; displays little or no psychotropic activity.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Zygmunt et al (2002) Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism. J.Neurosci. 22 4720. PMID: 12040079.
Herring et al (1998) Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kB elements by cannabinol, a minimally CNS-active cannabinoid. Biochem.Pharmacol. 55 1013. PMID: 9605425.
Rhee et al (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylyl cyclase. J.Med.Chem. 40 3228. PMID: 9379442.
If you know of a relevant reference for Cannabinol please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Cannabinol from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Cannabinol, supplier, cannabinoids, CB1, CB2, receptors, agonists, not, psychoactive, Tocris Bioscience, Non-selective Cannabinoid Agonist products
Find multiple products by catalog number
New Products in this Area
Potent and selective CB2 partial agonist; orally biovailable
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.